Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Stem Cell Research & Therapy|May 28, 2021
Use of constitutive and inducible oncogene-containing iPSCs as surrogates for transgenic mice to study breast oncogenesisChristine Nguyen, Julie P T Nguyen, Arnav P Modi, et al.Clinical Immunology (Orlando, Fla.)|December 18, 2015
Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responsesTheresa R Wilhelm, Adriano Taddeo, Oliver Winter, et al.The Journal of Biological Chemistry|April 20, 2000
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundleT Mirzadegan, F Diehl, B Ebi, et al.Scientific Reports|April 3, 2023
Food system actor perspectives on future-proofing European food systems through plant breedingS Stetkiewicz, J Menary, A Nair, et al.Cancer|September 21, 2019
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trialShelley A Johns, Patrick V Stutz, Tasneem L Talib, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Intratumoral plasma cells mediate CD8+ T cell infiltration and successful immune checkpoint blockade therapy in de novo MPNSTsJoshua J Lingo, Ryan Reis, Chantal Allamargot, et al.Ebiomedicine|August 1, 2026
Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumoursJoshua J Lingo, Ryan Reis, Altay Koyas, et al.Blood|May 16, 2023
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cellsRadoslaw Kaczmarek, Annie R Piñeros, Paige E Patterson, et al.Science Immunology|March 6, 2026
Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockadeAndrew J Snyder, Sarah M Garrison, Mitchell G Kluesner, et al.Pageof 9